299 papers found
Refreshing results…
The impact of ruxolitinib treatment on inflammation-mediated co-morbidities in myelofibrosis and related neoplasms
Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome
Smoking and philadelphia-negative chronic myeloproliferative neoplasms
Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients
A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms
WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect - the Danish experience
Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms
Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?
The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasms
Interferon therapy for myelofibrosis
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis
Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis
Association of the blood eosinophil count with hematological malignancies and mortality: The Blood Eosinophil Count
Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
Are Chronic Myeloproliferative Neoplasms Associated with Age-Related Macular Degeneration?
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms:A prospective Study
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
Missing publications? Read more about our data sources.